Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: Role of socio-behavioral factors and medical encounters

Journal of the Formosan Medical Association

Volumn 110, Issue 5, 2011, Pages 306-315

  Lo, Yi Chun ^a   Wu, Pei Ying ^a   Hsieh, Chia Yin ^a   Chen, Mao Yuan ^a   Sheng, Wang Huei ^a   Hsieh, Szu Min ^a   Sun, Hsin Yun ^a   Liu, Wen Chun ^a   Hung, Chien Ching ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Human immunodeficiency virus diagnosis; Human immunodeficiency virus infection; Human immunodeficiency virus testing; Late diagnosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DELAYED DIAGNOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SEBORRHEIC DERMATITIS; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR;

EID: 79960375295     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60046-6     Document Type: Article

References (37)

1. Marks G, Crepaz N, Senterfutt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005;39:446-53.
2. Castilla J, Del Romero J, Hernando V, et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005;40:96-101.
3. Centers for Disease Control and Prevention. Adoption of protective behaviors among persons with recent HIV infection and diagnosis-Alabama, New Jersey, and Tennessee, 1997-1998. MMWR Morb Mortal Weekly Rep 2000;49: 512-5.
4. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/μL) with HIV infection. HIV Med 2004;5:93-8.
5. Perbost I, Malafronte B, Pradier C, et al. In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection? HIV Med 2005;6:232-9.
6. Krawczyk CS, Funkhouser E, Kilby JM, et al. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J 2006;99:472-81.
7. Girardi E, Sabin CA, Monforter AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007;46(Suppl 1):S3-8.
8. Centers for Disease Control and Prevention. Late HIV testing-34 states, 1996-2005. MMWR Morb Mortal Wkly Rep 2009;58:661-5.
9. Brannstrom J, Akerlund B, Arneborn M, et al. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002. Int J STD AIDS 2005;16:702-6.
10. Boyd AE, Murad S, O'Shea S, et al. Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south London. HIV Med 2005;6:59-65.
11. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004;18:2145-51.
12. Sullivan AK, Curtis H, Sabin CA, et al. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005;330: 1301-2.
13. Delpierre C, Cuzin L, Lauwers-Cances V, et al. High-risk groups for late diagnosis of HIV infection: A need for rethinking testing policy in the general population. AIDS Patient Care STDS 2006;20:838-47.
14. Castilla J, Sobrino P, De La Fuente L, et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16:1945-51.
15. Girardi E, Aloisi MS, Arici C, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004;36:951-9.
16. Longo B, Pezzotti P, Boros S, et al. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care 2005;17:834-41.
17. McDonald AM, Li Y, Dore GJ, et al. Late HIV presentation among AIDS cases in Australia, 1992-2001. Aust NZ Public Health 2003;27:608-13.
18. Barry SM, Lloyd-Owen SJ, Madge SJ, et al. The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000. HIV Med 2002;3:129-34.
19. Burns F, Fenton KA, Morison L, et al. Factors associated with HIV testing among black Africans in Britain. Sex Transm Infect 2005;81:494-500.
20. Burns FM, Imrie JY, Nazroo J, et al. Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care 2007;19:102-8.
21. Chadborn TR, Baster K, Delpech VC, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005;19:513-20.
22. Manavi K, McMillan A, Ogilvie M, et al. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004;15:811-4.
23. Couturier E, Schwoebel V, Michon C, et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS 1998;12:795-800.
24. Wong KH, Lee SS, Low KH, et al. Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality. AIDS Patient Care STDS 2003;17: 461-9.
25. Kim JM, Cho GJ, Hong SK, et al. Epidemiology and clinical features of HIV infection/AIDS in Korea. Yonsei Med J 2003;44:363-70.
26. Thanawuth N, Chongsuvivatwong V. Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in Southern Thailand. AIDS Care 2008;20:43-50.
27. Hung CC, Chen MY, Hsieh SM, et al. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000;24:378-85.
28. Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care 2009;21:284-93.
29. Freedberg KA, Samet JH. Think HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med 1999;159:1994-2000.
30. Sun HY, Ko WC, Tsai JJ, et al. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009;104:877-84.
31. Hung CC, Hsiao CF, Chen MY, et al. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006;59:222-8.
32. Klein D, Hurley LB, Merrill D, et al. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003;32:143-52.
33. Ko NY, Lee HC, Hsu ST, et al. Differences in HIV disclosure by modes of transmission in Taiwanese families. AIDS Care 2007;19:791-8.
34. Tung WC, Farmer S, Ding K, et al. Stages of condom use and decisional balance among college students. Int Nurs Rev 2009;56:346-53.
35. Hung CC, Ko NY, Ko WC, et al. Amebiasis among patrons visiting gay saunas in Taiwan. HIV Med 2008;9:787-9.
36. Kung HC, Sun HY, Chen MY, et al. Human immunodeficiency virus testing among patients with tuberculosis at a university hospital in Taiwan, 2000 to 2006. J Formos Med Assoc 2009;108:320-7.
37. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006;55(RR14):1-17.